Litcius/Paper detail

MALAT1-dependent hsa_circ_0076611 regulates translation rate in triple-negative breast cancer

Chiara Turco, Gabriella Esposito, Alessia Iaiza, Frauke Goeman, Anna Benedetti, Enzo Gallo, Theodora Daralioti, Letizia Perracchio, Andrea Sacconi, Patrizia Pasanisi, Paola Muti, Claudio Pulito, Sabrina Strano, Zaira Ianniello, Alessandro Fatica, Mattia Forcato, Francesco Fazi, Giovanni Blandino, Giulia Fontemaggi

2022Communications Biology27 citationsDOIOpen Access PDF

Abstract

Vascular Endothelial Growth Factor A (VEGFA) is the most commonly expressed angiogenic growth factor in solid tumors and is generated as multiple isoforms through alternative mRNA splicing. Here, we show that lncRNA MALAT1 (metastasis-associated lung adenocarcinoma transcript 1) and ID4 (inhibitor of DNA-binding 4) protein, previously referred to as regulators of linear isoforms of VEGFA, induce back-splicing of VEGFA exon 7, producing circular RNA circ_0076611. Circ_0076611 is detectable in triple-negative breast cancer (TNBC) cells and tissues, in exosomes released from TNBC cells and in the serum of breast cancer patients. Circ_0076611 interacts with a variety of proliferation-related transcripts, included MYC and VEGFA mRNAs, and increases cell proliferation and migration of TNBC cells. Mechanistically, circ_0076611 favors the expression of its target mRNAs by facilitating their interaction with components of the translation initiation machinery. These results add further complexity to the multiple VEGFA isoforms expressed in cancer cells and highlight the relevance of post-transcriptional regulation of VEGFA expression in TNBC cells.

Topics & Concepts

Triple-negative breast cancerAlternative splicingVascular endothelial growth factor ACancer researchGene isoformMALAT1AngiogenesisTranslation (biology)Cancer cellBiologyMessenger RNABreast cancerRNA splicingMicrovesiclesRNA-binding proteinVascular endothelial growth factorMolecular biologyCancerRNAmicroRNAGeneGeneticsVEGF receptorsLong non-coding RNACircular RNAs in diseasesCancer-related molecular mechanisms researchRNA Research and Splicing